Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$22.25 +0.29 (+1.32%)
As of 07/3/2025 03:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

WRBY vs. STVN, GKOS, NARI, IRTC, TMDX, BLCO, SLNO, INSP, PRCT, and NVST

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry.

Warby Parker vs. Its Competitors

Warby Parker (NYSE:WRBY) and Stevanato Group (NYSE:STVN) are both mid-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

In the previous week, Stevanato Group had 4 more articles in the media than Warby Parker. MarketBeat recorded 8 mentions for Stevanato Group and 4 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.21 beat Stevanato Group's score of 0.87 indicating that Warby Parker is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
2 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stevanato Group
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

93.2% of Warby Parker shares are held by institutional investors. 18.2% of Warby Parker shares are held by insiders. Comparatively, 0.7% of Stevanato Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Stevanato Group has a net margin of 11.14% compared to Warby Parker's net margin of -1.79%. Stevanato Group's return on equity of 10.00% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker-1.79% -2.48% -1.29%
Stevanato Group 11.14%10.00%6.03%

Warby Parker currently has a consensus price target of $22.88, indicating a potential upside of 2.81%. Given Warby Parker's higher probable upside, analysts plainly believe Warby Parker is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
7 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.61
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86

Warby Parker has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.

Stevanato Group has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$771.32M3.01-$20.39M-$0.12-185.42
Stevanato Group€1.19B6.23€127.45M€0.5148.22

Summary

Stevanato Group beats Warby Parker on 11 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$2.32B$33.81B$16.44B$20.73B
Dividend YieldN/A2.68%3.10%3.72%
P/E Ratio-185.4233.1520.3328.09
Price / Sales3.011.8557.0138.31
Price / Cash65.5116.4914.8722.53
Price / Book6.648.896.184.58
Net Income-$20.39M$1.19B$685.51M$986.06M
7 Day Performance1.64%4.15%2.76%2.79%
1 Month Performance8.96%1.77%0.62%5.42%
1 Year Performance37.09%38.47%7.75%14.63%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
2.2282 of 5 stars
$22.25
+1.3%
$22.88
+2.8%
+37.1%$2.32B$771.32M-185.423,780
STVN
Stevanato Group
1.2594 of 5 stars
€23.62
+1.4%
N/A+36.8%€7.15B€1.19B46.315,521Positive News
Gap Down
GKOS
Glaukos
4.4512 of 5 stars
$96.80
-3.3%
$134.67
+39.1%
-13.1%$5.72B$383.48M-40.84780
NARI
Inari Medical
N/A$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
IRTC
iRhythm Technologies
1.0965 of 5 stars
$150.95
+3.6%
$138.60
-8.2%
+47.1%$4.65B$591.84M-48.072,000Insider Trade
TMDX
TransMedics Group
1.6385 of 5 stars
$127.53
+3.2%
$127.33
-0.2%
-13.9%$4.18B$441.54M93.77210Positive News
BLCO
Bausch + Lomb
3.3891 of 5 stars
$12.01
+2.3%
$15.54
+29.5%
-5.7%$4.15B$4.79B24.4413,500
SLNO
Soleno Therapeutics
4.3805 of 5 stars
$81.42
+1.8%
$107.10
+31.5%
+106.1%$4.03BN/A-17.6230Insider Trade
INSP
Inspire Medical Systems
4.8493 of 5 stars
$129.88
-0.8%
$211.91
+63.2%
-4.0%$3.86B$802.80M59.851,246
PRCT
PROCEPT BioRobotics
2.2752 of 5 stars
$58.74
-2.5%
$90.00
+53.2%
-7.3%$3.33B$224.50M-34.55430Positive News
NVST
Envista
3.7587 of 5 stars
$18.90
+0.1%
$20.23
+7.0%
+25.1%$3.20B$2.51B-2.8912,300News Coverage

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners